Biosergen AB (FRA:8N1) ROE % Adjusted to Book Value : -19.36% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Biosergen AB ROE % Adjusted to Book Value?

Biosergen AB's ROE % for the quarter that ended in Dec. 2024 was -49.18%. Biosergen AB's PB Ratio for the quarter that ended in Dec. 2024 was 2.54. Biosergen AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -19.36%.

Biosergen AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Biosergen AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosergen AB ROE % Adjusted to Book Value Chart

Biosergen AB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

-99.83

-89.07

-9.63

-28.84

Biosergen AB Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial												-25.35	-149.12	-62.17	-17.68	-19.36

Competitive Comparison of Biosergen AB's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Biosergen AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosergen AB's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosergen AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Biosergen AB's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Biosergen AB ROE % Adjusted to Book Value Calculation

Biosergen AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-73.26%	/	2.54
	=	-28.84%

Biosergen AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-49.18%	/	2.54
	=	-19.36%

Biosergen AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Biosergen AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosergen AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (FRA:8N1) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

BIOSGN:Sweden

Address

Fogdevreten 2, Solna, SWE, 17165

Website

https://www.biosergen.net

Biosergen AB is a biotech company developing innovative antifungal drugs based on latest biopharmaceutical research and development from laboratory facilities in Trondheim, Norway, and several other places worldwide. The company is developing BSG005, a potentially disruptive antifungal drug, which has demonstrated significant safety and potency advantages over competing antifungals.

Biosergen AB Headlines

No Headlines